BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ciechomska, Iwona Anna ^a   Przanowski, Piotr ^a   Jackl, Judyta ^a   Wojtas, Bartosz ^a   Kaminska, Bozena ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AZEPINE DERIVATIVE; ENZYME INHIBITOR; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; QUINAZOLINE DERIVATIVE;

ANTAGONISTS AND INHIBITORS; AUTOPHAGY; BRAIN TUMOR; CANCER STEM CELL; CELL DIFFERENTIATION; DOSE RESPONSE; DRUG EFFECT; GLIOBLASTOMA; HUMAN; PATHOLOGY; TUMOR CELL CULTURE;

AUTOPHAGY; AZEPINES; BRAIN NEOPLASMS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLIOBLASTOMA; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; NEOPLASTIC STEM CELLS; QUINAZOLINES; TUMOR CELLS, CULTURED;

EID: 85005959198     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38723     Document Type: Article

References (60)

1. Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459-466, doi: 10.1016/S1470-2045(09)70025-7 (2009).
2. Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64, 7011-7021, doi: 10.1158/0008-5472.CAN-04-1364 (2004).
3. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760, doi: 10.1038/nature05236 (2006).
4. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401, doi: 10.1038/nature03128 (2004).
5. Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522-526, doi: 10.1038/nature11287 (2012).
6. Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev 29, 1203-1217, doi: 10.1101/gad.261982.115 (2015).
7. Huang, Z., Cheng, L., Guryanova, O. A., Wu, Q. & Bao, S. Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting. Protein Cell 1, 638-655, doi: 10.1007/s13238-010-0078-y (2010).
8. Suvà, M. L. et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157, 580-594, doi: 10.1016/j.cell.2014.02.030 (2014).
9. Binello, E. & Germano, I. M. Targeting glioma stem cells: a novel framework for brain tumors. Cancer Sci 102, 1958-1966, doi: 10.1111/j.1349-7006.2011.02064.x (2011).
10. Campos, B. et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 16, 2715-2728, doi: 10.1158/1078-0432.CCR-09-1800 (2010).
11. Campos, B. et al. Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma. Glia 63, 1850-1859, doi: 10.1002/glia.22849 (2015).
12. Choschzick, I. et al. Responsiveness of stem-like human glioma cells to all-trans retinoic acid and requirement of retinoic acid receptor isotypes α , β and γ . Neuroscience 279, 44-64, doi: 10.1016/j.neuroscience.2014.07.078 (2014).
13. Piccirillo, S. G. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761-765, doi: 10.1038/nature05349 (2006).
14. Chirasani, S. R. et al. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Brain 133, 1961-1972, doi: 10.1093/brain/awq128 (2010).
15. Lee, J. et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastomainitiating cells. Cancer Cell 13, 69-80, doi: 10.1016/j.ccr.2007.12.005 (2008).
16. Yan, K. et al. Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev 28, 1085-1100, doi: 10.1101/gad.235515.113 (2014).
17. Zhao, Y. et al. Autophagy impairment inhibits differentiation of glioma stem/progenitor cells. Brain research 1313, 250-258, doi: 10.1016/j.brainres.2009.12.004 (2010).
18. Zhuang, W. et al. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. International journal of cancer. Journal international du cancer 129, 2720-2731, doi: 10.1002/ijc.25975 (2011).
19. Zhuang, W. et al. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 103, 684-690, doi: 10.1111/j.1349-7006.2011.02198.x (2012).
20. Nabissi, M. et al. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner. Int J Cancer 137, 1855-1869, doi: 10.1002/ijc.29573 (2015).
21. Klionsky, D. J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8, 931-937, doi: 10.1038/nrm2245 (2007).
22. Yang, Z. & Klionsky, D. J. Mammalian autophagy: core molecular machinery and signaling regulation. Current opinion in cell biology 22, 124-131, doi: 10.1016/j.ceb.2009.11.014 (2010).
23. White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nature reviews. Cancer 12, 401-410, doi: 10.1038/nrc3262 (2012).
24. Maycotte, P. & Thorburn, A. Autophagy and cancer therapy. Cancer Biol Ther 11, 127-137 (2011).
25. Phadwal, K., Watson, A. S. & Simon, A. K. Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging. Cell Mol Life Sci 70, 89-103, doi: 10.1007/s00018-012-1032-3 (2013).
26. Füllgrabe, J., Klionsky, D. J. & Joseph, B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol 15, 65-74, doi: 10.1038/nrm3716 (2014).
27. Tachibana, M., Sugimoto, K., Fukushima, T. & Shinkai, Y. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276, 25309-25317, doi: 10.1074/jbc.M101914200 (2001).
28. Artal-Martinez de Narvajas, A. et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol 33, 3983-3993, doi: 10.1128/MCB.00813-13 (2013).
29. Kubicek, S. et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25, 473-481, doi: 10.1016/j.molcel.2007.01.017 (2007).
30. Kim, Y. et al. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy 9, 2126-2139, doi: 10.4161/auto.26308 (2013).
31. Ke, X. X. et al. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS One 9, e106962, doi: 10.1371/journal.pone.0106962 (2014).
32. Savickiene, J., Treigyte, G., Stirblyte, I., Valiuliene, G. & Navakauskiene, R. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation. Leuk Res 38, 822-829, doi: 10.1016/j.leukres.2014.04.003 (2014).
33. Ren, A., Qiu, Y., Cui, H. & Fu, G. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma. Biochem Biophys Res Commun 459, 10-17, doi: 10.1016/j.bbrc.2015.01.068 (2015).
34. Fan, J. D. et al. The selective activation of p53 target genes regulated by SMYD2 in BIX-01294 induced autophagy-related cell death. PLoS One 10, e0116782, doi: 10.1371/journal.pone.0116782 (2015).
35. Maleszewska, M., Steranka, A. & Kaminska, B. The effects of selected inhibitors of histone modifying enzyme on C6 glioma cells. Pharmacol Rep 66, 107-113, doi: 10.1016/j.pharep.2013.08.011 (2014).
36. Culmes, M. et al. Endothelial differentiation of adipose-derived mesenchymal stem cells is improved by epigenetic modifying drug BIX-01294. Eur J Cell Biol 92, 70-79, doi: 10.1016/j.ejcb.2012.11.001 (2013).
37. Ling, B. M. et al. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Natl Acad Sci USA 109, 841-846, doi: 10.1073/pnas.1111628109 (2012).
38. Mezentseva, N. V. et al. The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells. Stem Cells Dev 22, 654-667, doi: 10.1089/scd.2012.0181 (2013).
39. Yang, J., Kaur, K., Ong, L. L., Eisenberg, C. A. & Eisenberg, L. M. Inhibition of G9a Histone Methyltransferase Converts Bone Marrow Mesenchymal Stem Cells to Cardiac Competent Progenitors. Stem Cells Int 2015, 270428, doi: 10.1155/2015/270428 (2015).
40. Shi, Y. et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574, doi: 10.1016/j.stem.2008.10.004 (2008).
41. Tao, H. et al. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells. Mol Cell Biochem 394, 23-30, doi: 10.1007/s11010-014-2077-4 (2014).
42. Ying, M. et al. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene 30, 3454-3467, doi: 10.1038/onc.2011.58 (2011).
43. Di Tomaso, T. et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res 16, 800-813, doi: 10.1158/1078-0432.CCR-09-2730 (2010).
44. Chiao, M. T., Cheng, W. Y., Yang, Y. C., Shen, C. C. & Ko, J. L. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Autophagy 9, 1509-1526, doi: 10.4161/auto.25664 (2013).
45. Mizushima, N. & Levine, B. Autophagy in mammalian development and differentiation. Nat Cell Biol 12, 823-830, doi: 10.1038/ncb0910-823 (2010).
46. Vessoni, A. T., Muotri, A. R. & Okamoto, O. K. Autophagy in stem cell maintenance and differentiation. Stem Cells Dev 21, 513-520, doi: 10.1089/scd.2011.0526 (2012).
47. Dirks, P. B. Brain tumor stem cells: the cancer stem cell hypothesis writ large. Mol Oncol 4, 420-430, doi: 10.1016/j.molonc.2010.08.001 (2010).
48. Ciechomska, I., Kocyk, M. & Kaminska, B. Glioblastoma Stem-Like Cells-Isolation, Biology and Mechanisms of Chemotherapy Resistance. Current Signal Transduction Therapy 8, 256-267 (2013).
49. Jiang, H. et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death. Journal of the National Cancer Institute 99, 1410-1414, doi: 10.1093/jnci/djm102 (2007).
50. Lomonaco, S. L. et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. International journal of cancer. Journal international du cancer 125, 717-722, doi: 10.1002/ijc.24402 (2009).
51. Ciechomska, I. A., Gabrusiewicz, K., Szczepankiewicz, A. A. & Kaminska, B. Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine A-induced cell death. Oncogene 32, 1518-1529, doi: 10.1038/onc.2012.174 (2013).
52. Gong, C. et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene 32, 2261-2272, 2272e.2261-2211, doi: 10.1038/onc.2012.252 (2013).
53. Salemi, S., Yousefi, S., Constantinescu, M. A., Fey, M. F. & Simon, H. U. Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell Res 22, 432-435, doi: 10.1038/cr.2011.200 (2012).
54. Vázquez, P. et al. Atg5 and Ambra1 differentially modulate neurogenesis in neural stem cells. Autophagy 8, 187-199, doi: 10.4161/auto.8.2.18535 (2012).
55. Zeng, M. & Zhou, J. N. Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells. Cell Signal 20, 659-665, doi: 10.1016/j.cellsig.2007.11.015 (2008).
56. Guan, J. L. et al. Autophagy in stem cells. Autophagy 9, 830-849, doi: 10.4161/auto.24132 (2013).
57. Persano, L. et al. BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression. Cell Death Dis 3, e412, doi: 10.1038/cddis.2012.153 (2012).
58. Roy Choudhury, S., Karmakar, S., Banik, N. L. & Ray, S. K. Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells. Neurochem Res 36, 2292-2305, doi: 10.1007/s11064-011-0554-7 (2011).
59. Mazzoleni, S. et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 70, 7500-7513, doi: 10.1158/0008-5472.CAN-10-2353 (2010).
60. Ciechomska, I. et al. Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. Int J Cancer 117, 59-67, doi: 10.1002/ijc.21153 (2005).